Live Analyst Rating Changes 35130 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Hassan Al-Wakeel
BARC

Hassan Al-Wakeel

Barclays
Wall Street Analyst
★★★★☆
#796
on 13Foresight · ranked by our own returns
52%
Success Rate
+1.4%
Average Return
22 of 42 calls profitable · +30.0% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 52% of Hassan Al-Wakeel's ratings turned a profit when each position was held for 1 year — averaging +1.4% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

104 Buy 39 Hold 19 Sell
Hassan's Stock Coverage 18 ratings · 2026-09-28
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
GB:SN
Smith & Nephew
 Sep 25, 2026 SELL Buy
+1305.2% avg upside
17 analysts
$1050.00
4.09% Upside
 · ·
CH:SOON
Sonova Holding AG
 Sep 24, 2026 SELL Hold
-7.5% avg upside
18 analysts
$175.00
27.42% Downside
 -0.0% ·
GB:0K9P
GN Store Nord
 Sep 23, 2026 BUY Hold
+127.6% avg upside
13 analysts
$121.00
15.12% Upside
 · ·
DE:FRE
Fresenius SE & Co. KGaA
 Sep 16, 2026 BUY Strong Buy
+10.2% avg upside
20 analysts
$57.50
24.53% Upside
 +0.1% ·
GB:SPI
Spire Healthcare
 Sep 08, 2026 BUY Strong Buy
+16.5% avg upside
6 analysts
$275.00
12.05% Upside
 -0.2% ·
SE:EKTA.B
Elekta AB
 Aug 31, 2026 SELL Sell
+16.0% avg upside
12 analysts
$45.50
10.44% Downside
 +1.7% ·
CH:STMN
Straumann Holding AG
 Aug 19, 2026 BUY Strong Buy
+31.9% avg upside
15 analysts
$119.00
21.99% Upside
 +1.5% ·
GB:0QBO
Coloplast A/S
 Aug 18, 2026 HOLD Buy
+74.3% avg upside
17 analysts
$495.00
18.86% Upside
 · ·
WILLF
Demant
 Aug 13, 2026 HOLD Strong Buy
-5.5% avg upside
19 analysts
$41.14
9.78% Downside
 +1.5% ·
DE:FME
Fresenius Medical Care AG & Co. KGaA
 Aug 06, 2026 HOLD Hold
+25.7% avg upside
23 analysts
$44.50
11.86% Upside
 -5.3% ·
GB:CTEC
ConvaTec
 Aug 05, 2026 BUY Strong Buy
+42.0% avg upside
18 analysts
$300.00
43.20% Upside
 -7.7% ·
DE:SHL
Siemens Healthineers AG
 Aug 03, 2026 BUY Buy
+28.0% avg upside
24 analysts
$47.50
25.74% Upside
 -3.1% ·
IT:AMP
Amplifon S.p.A.
 Aug 03, 2026 BUY Buy
+98.7% avg upside
14 analysts
$11.50
0.74% Upside
 -4.9% ·
FR:EL
EssilorLuxottica SA
 Jul 30, 2026 BUY Strong Buy
+31.5% avg upside
18 analysts
$265.00
84.22% Upside
 -12.3% ·
NL:PHIA
Koninklijke Philips N.V.
 May 07, 2026 BUY Buy
+37.6% avg upside
21 analysts
$29.50
34.81% Upside
 -1.8% ·
GB:ONT
Oxford Nanopore Technologies PLC
 Mar 12, 2026 BUY Strong Buy
+16.0% avg upside
7 analysts
$170.00
6.30% Downside
 +43.8% ·
SE:VIMIAN
Vimian Group AB
 Oct 23, 2025 HOLD Hold
+0.6% avg upside
2 analysts
$37.00
3.89% Upside
 -5.2% ·
FSNUY
Fresenius SE & Co
 Feb 18, 2019 HOLD Strong Buy
-20.9% avg upside
7 analysts
 — +0.9% ·
🔒 13 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Hassan Al-Wakeel — Frequently Asked Questions
How accurate are Hassan Al-Wakeel's stock ratings?
Based on the calls 13Foresight could measure, about 52% of Hassan's ratings were profitable over a one-year hold, with an average return of +1.4% per rating, or +30.0% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Hassan ranked on 13Foresight?
Hassan Al-Wakeel is currently ranked #796 with a 4-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Hassan cover?
Hassan most recently has ratings on GB:SN, CH:SOON, GB:0K9P, DE:FRE, GB:SPI, SE:EKTA.B, CH:STMN, GB:0QBO, WILLF, DE:FME, GB:CTEC, DE:SHL and 6 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.